Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes

International Journal of Cardiology

Volumn 130, Issue 3, 2008, Pages 503-504

  Wainstein, Marco V ^a   Bento da Silva, Diego P ^a   Ribeiro, Jorge P ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acute coronary syndromes; CD40; Stent

Indexed keywords

CD40 LIGAND;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; ELECTIVE SURGERY; FEMALE; HUMAN; INFLAMMATION; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CD40 LIGAND; FEMALE; HUMANS; MALE; MIDDLE AGED; STENTS;

EID: 55649112495     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.051     Document Type: Article

References (10)

1. Davies M.J. Stability and instability: two faces of coronary atherosclerosis. Circulation 94 (1996) 2013-2020
2. Davies M.J. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 82 Suppl II (1990) II-38-II-46
3. Davies M.J. The composition of coronary-artery plaques. N Engl J Med 336 (1997) 1312-1314
4. Andre P., Nannizzi-Alaimo L., Prasad S.K., and Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106 (2002) 896-899
5. Schonbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58 (2001) 4-43
6. Henn V., Steinbach S., Buchner K., et al. The inflammatory action of CD40 ligand (CD154) expressed on actived humans platelets is temporally limited by coexpressed CD40. Blood 98 (2001) 1047-1054
7. Henn V., Slupsky J., Grafe M., et al. CD40 ligand on actived platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998) 591-594
8. Heeschen C., Dimmeler F., Hamm C.W., et al. Soluble CD40 ligand in ACSs. N Engl J Med 348 (2003) 1104-1111
9. Carbone G.L., Oxvig C., Medda M., et al. Plaque sealing with stenting is associated with marked reduction of biologic markers of vulnerability. Am J Cardiol 92 (2003) 5L
10. Garlichs C.D., Eskafi S., Raaz D., et al. Patients with ACSs express enhanced CD40 ligand /CD154 on platelets. Heart 86 (2001) 649-655